Yonghe HK$1.49 billion IPO
The shares are listed on the HKEX
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
CANbridge Pharmaceuticals HK$685 million IPO
We advised CANbridge Pharmaceuticals on its IPO and HKEX listing
Bilibili $1.6 billion sustainable convertible notes offering
The 0.5% convertible senior notes are due 2026
ANE HK$1.1 billion IPO
We advised ANE on its IPO and HKEX listing
Yili Group HK$6.25 billion acquisition of 34.33% of Ausnutria Dairy
We advised Yili on the acquisition of a controlling interest in Ausnutria
MicroTech Medical HK$1.82 billion IPO
We advised MicroTech Medical on its IPO and HKEX listing
Abbisko HK$1.7 billion IPO
We advised Abbisko on its IPO and HKEX listing
Broncus Holding HK$1.55 billion IPO
We advised Broncus on its IPO and HKEX listing
Sands China $1.95 billion notes offering
We advised the joint book-running managers on the investment-grade debt offering
Sea $6.9 billion concurrent convertible notes and equity offerings
We advised the joint book-running managers on the concurrent offerings of convertible senior notes and ADSs